Navigation Links
Herborium(R) Group Discusses an Aftermath of the Ban of Diane-35 Acne Drug Due to Number of Deaths
Date:2/4/2013

FORT LEE, N.J., Feb. 4, 2013 /PRNewswire/ -- Herborium Group, Inc., (OTC Pink: HBRM) www.herborium.com, a Botanical Therapeutics® Company discusses an impact of a ban of Bayer's Diana-35 acne drug in Europe, and a follow up investigation in Canada, on Herborium' s all botanical acne treatment -AcnEase®.

Diane-35 is a hormonal drug used to treat hormonal acne, especially those resulting from too much of androgens (male hormones). It is also an oral contraceptive (birth control pill). Diane-35 is not approved in the US but it was available in Canada. Like many other drugs Diane-35 found its way to US consumers though so called "gray marketing".

Diane-35 is presently investigated in Europe and Canada for number of deaths, caused by blood clots, and for non-fatal cases of thrombosis and arterial thrombosis associated with a use of a drug.

In September 2011, the U.S. Food and Drug Administration (FDA) has informed the public that it has not yet reached a conclusion, but remains concerned, about the potential increased risk of blood clots with the use of drospirenone-containing birth control pills.  Number of US approved contraceptive pills including very popular Yasmin and Yuz were put on a warning list.  Despite of the warning, birth control pills are still rather liberally prescribed to women with acne even if their sexual activity is not a factor.

AcnEase® is all botanical ingredients based product that DOES NOT INCLUDE ANY ESTROGEN. Furthermore, AcnEase® also DOES NOT include any phytoestrogens   (plant-derived estrogen-like substance). As phytoestrogens may be considered safer that those made chemically they still act in a similar way and therefore may not be suitable or safe for some consumers especially teens, women that want to become pregnant, those who are pregnant or nursing, and of course men suffering from hormonal acne.

"We are deeply saddened by a death and potential serious health implication among Diane-35 patients. We are also determined to reiterate to our investors and customers that a decision to base Herborium's differential advantage on the use of proprietary, validated and safe botanical formulas has once again been proven correct and most advantageous both strategically and ethically. We will continue to provide safe and up to 96% effective AcnEase® to acne sufferers in all markets, and to grow our market share in the multi-billion dollar world-wide acne treatment sector," commented Dr. Agnes P. Olszewski , CEO and Chairwomen of Herborium Group.  

About Herborium Group, Inc. 

Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals.  The Company uses clinical validation to establish and maintain a differential advantage.  The company sells its products in the US and Europe. For more information, please visit www.herborium.com and www.acnease.com

One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.

For more information please inquire: Investorsrelations@herborium.com

 


'/>"/>
SOURCE Herborium Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. InternetArray Collaborates with Health Sciences Group to Fund Medical Marijuana Social Media/Mobile Apps Development
2. NSF International Acquires the INASSA Group LLC, a Peruvian Leader in Analytical Testing, Certification, Inspection and Training for the Seafood/Fishing, Food and Pharmaceutical/Medical Industries
3. Health Diagnostic Laboratory, Inc. and Global Genomics Group join forces to form a new scientific process
4. Foundation Venture Capital Group Invests In Start-Up Working to Reduce Side Effects of Parkinsons Treatment
5. Pro-Dex, Inc. And AO Partners Group Jointly Announce Voting Results
6. Simcere Pharmaceutical Group Announces Sale of Equity Interest in Shanghai Celgen
7. Maximizing the Effectiveness of Market Research Groups through Outsourcing and Automation
8. Global Medical Device Marketing Groups Respond to Internal Cost Pressures
9. NYSE Hot Stocks Earnings Forecast: Wells Fargo, Eli Lilly, Berkshire Hathaway, Coca-Cola, Valero Energy, and Altria Group
10. Earnings Forecast Stock Alerts: American International Group, Teva Pharmaceutical, CSX, Exxon Mobil, Lowes, and Seagate
11. Cloudnine Group of Hospitals Delivers 12 Babies by Mid-day on 12/12/12
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... -- Research and Markets has announced the addition of ... to their offering. ... The global fluoropolymer market in the healthcare industry to grow ... Global Fluoropolymer Market in the Healthcare Industry 2016-2020, has been ... experts. The report covers the market landscape and its growth prospects ...
(Date:1/17/2017)... Jan. 17, 2017 Following an initial ... praised the Food and Drug Administration,s (FDA,s) final ... Drug Products by Pharmacies and Outsourcing Facilities." In ... limitation on pre-packaging -- which would have put ... to long term care (LTC) pharmacies.  ...
(Date:1/17/2017)... ReportsnReports.com adds "Anaphylaxis - Pipeline Review, H2 2016" ... Anaphylaxis,s therapeutic pipeline with comprehensive information on the therapeutic development ... assessment by drug target, mechanism of action (MoA), route of ... featured news and press releases. ... Complete report on H2 2016 pipeline ...
Breaking Medicine Technology:
(Date:1/17/2017)... ... January 17, 2017 , ... Achieve ... Desert, is opening a new office in San Clemente, California this month. Achieve ... in Southern California, successfully treating individuals struggling with major depression. Depression impacts over ...
(Date:1/17/2017)... , ... January 17, 2017 , ... ... – will lecture to primary eye care practitioners on the latest breakthroughs in ... upcoming 13th Semi-Annual Continuing Education Symposium, according to eye surgeon, Jeffrey Martin, MD, ...
(Date:1/17/2017)... ... January 17, 2017 , ... Wettstein Agencies, a Denver ... business professionals throughout central Colorado, is joining local nonprofit Aurora Warms The Night ... The Night organization is committed to breaking the cycle of homelessness and poverty ...
(Date:1/17/2017)... ... January 17, 2017 , ... Physicians Education Review®, LCC (PER®) ... speaker for the 34th Annual Miami Breast Cancer Conference®, on March 9-12, 2017 ... Phil Talamo, said, “We are delighted to have Sandra Lee join us as ...
(Date:1/17/2017)... ... January 17, 2017 , ... Today, FloSports , a ... announced a new agreement as part of a long-term extension of their media partnership. ... the airing of some of the sport’s premier events exclusively on FloWrestling.com as well ...
Breaking Medicine News(10 mins):